Global Transcriptomics Market 2016-2020

  • ID: 3883895
  • Report
  • Region: Global
  • 78 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5
Transcriptomics: the Future of Health Technology

FEATURED COMPANIES

  • Agilent Technologies
  • Becton
  • bioMérieux
  • Cepheid
  • Cytognomix
  • Edico Genome
  • MORE
About Transcriptomics

Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. The transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. The difference in genetic expression symbolizes the wide-ranging biochemical and physical differences present among various cells and tissues that may cause genetic disorders.

The analysts forecast the global transcriptomics market to grow at a CAGR of 14.10% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global transcriptomics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the transcriptomics consumables, and transcriptomics instruments.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Transcriptomics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Agilent Technologies
- Illumina
- Roche Diagnostics
- Thermo Fisher Scientific

Other prominent vendors
- Beckman Coulter
- Becton
- Dickinson and Company
- Biological Industries
- bioMérieux
- Bio-Rad Laboratories
- Cepheid
- Clontech Laboratories
- Cytognomix
- Edico Genome
- Eppendorf
- Fluidigm
- GE Healthcare
- Harvard Bioscience
- Kapa Biosystems
- Leica Biosystems
- Maxim Biotech
- Molecular Devices
- Oxford Gene Technology
- PerkinElmer
- Promega
- Qiagen
- RainDance Technologies
- Siemens Healthcare
- Sigma-Aldrich

Market drivers
- Wide range of PCR applications
- For a full, detailed list, view the full report

Market challenges
- Ethical challenges in stem cell research
- For a full, detailed list, view the full report

Market trends
- Ethical challenges in stem cell research
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agilent Technologies
  • Becton
  • bioMérieux
  • Cepheid
  • Cytognomix
  • Edico Genome
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Vendor segmentation
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product type
  • Market overview
  • Global transcriptomics consumables market
  • Global transcriptomics instruments market
PART 07: Market segmentation by technology
  • PCR
  • NGS
  • RNAi
  • Microarray
PART 08: Market segmentation by PCR technology
  • Market overview
  • qPCR
  • Standard PCR
  • dPCR
PART 09: Geographical segmentation
  • Global transcriptomics market by geography
  • Transcriptomics market in Americas
  • Transcriptomics market in EMEA
  • Transcriptomics market in APAC
PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
  • Competitive scenario
PART 16: Key Vendor Analysis
  • Agilent Technologies
  • Illumina
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

List of Exhibits
Exhibit 01: Key countries
Exhibit 02: Global transcriptomics market segmentation: Overview
Exhibit 03: Product offerings
Exhibit 04: Advantages of transcriptomics
Exhibit 05: Key applications of transcriptomics
Exhibit 06: Global transcriptomics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global transcriptomics market by product type 2015 and 2020
Exhibit 09: Global transcriptomics market by product type 2015-2020
Exhibit 10: Global transcriptomic consumables market 2015-2020 ($ billions)
Exhibit 11: Global transcriptomics instruments market 2015-2020 ($ billions)
Exhibit 12: Global transcriptomics market by technology 2015 and 2020
Exhibit 13: Global PCR market by technology 2015 and 2020
Exhibit 14: Technology lifecycle of PCR 2015
Exhibit 15: Benefits of qPCR technology
Exhibit 16: Benefits of dPCR technology
Exhibit 17: Global transcriptomics market by geography 2015 and 2020
Exhibit 18: Global transcriptomics market by geography 2015-2020
Exhibit 19: Transcriptomics market in Americas 2015-2020 ($ billions)
Exhibit 20: Export of biopharmaceutical goods from US 2007-2015 ($ billions)
Exhibit 21: Transcriptomics market in EMEA 2015-2020 ($ millions)
Exhibit 22: Population over 65 years of age in EMEA
Exhibit 23: Transcriptomics market in APAC 2015-2020 ($ millions)
Exhibit 24: Major chronic disease-related deaths 2012 (in thousands)
Exhibit 25: Applications of PCR technology
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Competitive parameters in global transcriptomics market
Exhibit 29: Agilent Technologies: Key takeaways
Exhibit 30: Illumina: Key takeaways
Exhibit 31: Roche Diagnostics: Key takeaways
Exhibit 32: Thermo Fisher Scientific: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Agilent Technologies
  • Becton
  • bioMérieux
  • Cepheid
  • Cytognomix
  • Edico Genome
  • MORE
New Report Released: – Global Transcriptomics Market 2016-2020

The author of the report recognizes the following companies as the key players in the global transcriptomics market: Agilent Technologies, Illumina, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Becton, Dickinson and Company, Biological Industries, bioMérieux, Bio-Rad Laboratories, Cepheid, Clontech Laboratories, Cytognomix, Edico Genome, Eppendorf, Fluidigm, GE Healthcare, Harvard Bioscience, Kapa Biosystems, Leica Biosystems, Maxim Biotech, Molecular Devices, Oxford Gene Technology, PerkinElmer, Promega, Qiagen, RainDance Technologies, Siemens Healthcare, and Sigma-Aldrich.

Commenting on the report, an analyst from the research team said: “Growing popularity of single cell transcriptomics will be a key trend for market growth. Conventionally, transcriptomics for gene expression measurements were used for bulk sampling that included many cells. However, advances in technology, coupled with the need for specific analysis and results, have driven the need for single cell transcriptomics, which has been extensively used for analyzing rare cell populations such as circulating tumor cells, cancer stem cells in solid tumors, and embryonic stem cells in mammalian blastocysts. Technological advances in single cell transcriptomics have enabled users to carry out live cell imaging and lineage tracing.”

According to the report, one of the key drivers for market growth will be rise in strategic initiatives among vendors. Globally, there has been an increase in strategic initiatives among vendors in the transcriptomics market, which has significantly impacted demand in different regions. Strategic initiatives are primarily to leverage on each other’s USP and that could be a strong customer base, technology, strong financial capability, or R&D capabilities to increase market share and strongly establish presence in the transcriptomics market. For instance, in February 2014, Thermo Fisher (based in the US) acquired Life Technologies for $13.6 billion, which includes business divisions such as sera and media, chromatography instruments, purification consumables, and DNA sequencing. The combination of these two companies will provide access to advance technologies for genomics and proteomics, to accelerate life sciences research. Apart from helping the concerned vendors to expand their respective product portfolios, strategic initiatives have helped global vendors to venture into untapped markets, especially in developing countries, to launch products by leveraging on a local player’s market presence.

Further, the report states that commercialization of transcriptomics products is a challenging process. Some of its products come under the medical devices category as they are used by physicians for diagnostic purposes. The FDA categorizes medical devices, including the ones used for conducting genetic tests (including transcriptomics solutions), into three separate classes, ranging from class I (for relatively low risk products), to class III, (tests are subject to the greatest level of scrutiny). Therefore, they cannot be marketed without successfully completing clinical trials, which is a time consuming, expensive, and uncertain process. The regulations for approval on diagnostics devices vary across countries, which is a major challenge faced by MNCs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Agilent Technologies
- Illumina
- Roche Diagnostics
- Thermo Fisher Scientific
- Beckman Coulter
- Becton
- Dickinson and Company
- Biological Industries
- bioMérieux
- Bio-Rad Laboratories
- Cepheid
- Clontech Laboratories
- Cytognomix
- Edico Genome
- Eppendorf
- Flui
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll